Heterophilic antibody blocker for BEK-2212 and similar ELISA assays-500 µg BL-005-500
Der In den Warenkorb Knopf erscheint sobald die obigen Werte ausgewählt wurden
Spezifikationen
| 500 µg |
BL-005-500 contains a proprietary mixture of proteins and buffer reagents designed to reduce heterophilic interactions in ELISA assays utilizing mouse immunoreagents.
Following ELISA assays in the Biosensis RapidTM ELISA range have been validated to achieve accurate results using BL-005-500:
BEK-2212, Human NGF; Application: Citrate-Plasma
One vial of BL-005-500 contains 500 μg IgG which is sufficient as sample diluent additive for one 96-well plate.
Other ELISA assays that use mouse assay antibodies may also benefit from addition of blocker BL-005-500, but require optimization of working concentration and assay validation for accurate results.
Following ELISA assays in the Biosensis RapidTM ELISA range have been validated to achieve accurate results using BL-005-500:
BEK-2212, Human NGF; Application: Citrate-Plasma
One vial of BL-005-500 contains 500 μg IgG which is sufficient as sample diluent additive for one 96-well plate.
Other ELISA assays that use mouse assay antibodies may also benefit from addition of blocker BL-005-500, but require optimization of working concentration and assay validation for accurate results.
